Cleared Traditional

MEDRAD QUAD C-SPINE COIL, 1.5T MODEL, M64CSC, 1.0T MODEL M42CSC (K982959) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K982959 · Medrad, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1998
Decision
71d
Days
Class 2
Risk

K982959 is an FDA 510(k) clearance for the MEDRAD QUAD C-SPINE COIL, 1.5T MODEL, M64CSC, 1.0T MODEL M42CSC. Classified as System, Nuclear Magnetic Resonance Imaging (product code LNH), Class II - Special Controls.

Submitted by Medrad, Inc. (Indianola, US). The FDA issued a Cleared decision on November 3, 1998 after a review of 71 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1000 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Medrad, Inc. devices

Submission Details

510(k) Number K982959 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 24, 1998
Decision Date November 03, 1998
Days to Decision 71 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
36d faster than avg
Panel avg: 107d · This submission: 71d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LNH System, Nuclear Magnetic Resonance Imaging
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1000
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LNH System, Nuclear Magnetic Resonance Imaging

All 431
Devices cleared under the same product code (LNH) and FDA review panel - the closest regulatory comparables to K982959.
QUANTITATIVE FLOW
K992225 · Philips Medical Systems (Cleveland), Inc. · Sep 1999
MRGP OPTICAL TRACKING UNIT
K991943 · Philips Medical Systems (Cleveland), Inc. · Aug 1999
IPASS BOLUS TRACKING
K992412 · Philips Medical Systems (Cleveland), Inc. · Aug 1999
ACTIVE ECG ELECTRODES MAGNETOM VISION SYSTEMS
K983327 · Siemens Medical Solutions USA, Inc. · Oct 1998
IMAGE POST-PROCESSING TECHNIQUES
K980831 · Philips Medical Systems (Cleveland), Inc. · Aug 1998
HAMMERSMITH ENDOCAVITARY COILS
K981410 · Philips Medical Systems (Cleveland), Inc. · Jun 1998